Uramoto, Hidetaka https://orcid.org/0000-0003-4451-4225
Takiguchi, Tomoya
Koizumi, Tomonobu
Tanimoto, Azusa
Hayashi, Ryuji
Nakazawa, Yozo
Ito, Ken-ichi
Nakada, Mitsutoshi
Hirono, Yasuo
Nishino, Yoshikazu
Yano, Seiji
Article History
Received: 23 March 2021
Accepted: 14 June 2021
First Online: 29 June 2021
Declarations
:
: TK received honoraria for AstraZeneca Co. LTD, and Ono Pharmaceutical Co., LTD. MN received honoraria for Daiichi Sankyo Company and Eisai Japan Co and received a research grant from Eisai Japan Co. All other authors declared no conflict of interest.
: The present protocol was approved by the Kanazawa University Institutional Review Board (IRB) (reference number 2750-2), Kanazawa Medical University (I328), and the IRBs at Hokushin Ganpro database project, all of which granted a waiver of consent for the study.
: Not applicable.